Humalog U-200 KwikPen holds twice as many units of insulin (600 units vs. 300 units) as the U-100 formulation in the same three-milliliter cartridge. This offers patients a pen that lasts longer between pen changes, allowing for fewer changes every month. Humalog U-200 KwikPen delivers the same dose in …
Read More »Monthly Archives: May 2015
Humalog 200U/ml KwikPen Patient and Prescribing information
Please follow these links to access Full Prescribing Information (PDF) and Patient Information (PDF) on the Humalog 200U/Ml KwikPen.
Read More »U.S. FDA Approves Eli Lillys Humalog® 200 units/mL KwikPen®
See the Product of the Week.
Read More »Letter from the Editor, #783
Last week in our SGLT- Inhibitor Special Edition for May, we discussed the idea of early adopters using the complete arsenal of diabetes medications for both type 1 and type 2 patients. When I mentioned that one of our advisory board members, Dr. Stanley Schwartz, sets a high bar in using …
Read More »Editor’s Note, SGLT-2 Inhibitors Special Edition, May 2015
Sometimes the early adopters receive a little scorn from their colleagues for "jumping on the bandwagon" too early. However it seems that usually sooner or later everyone else comes over to their way of thinking and the "experimental" becomes the norm. A good example of this is the use of …
Read More »Editor’s Note, DCMS #242
We often threaten our patients with the complications of diabetes to try to get them to work on their diabetes. Kidney failure and dialysis are the most scary ones that we can talk about. But what happens when we finally have to start a patient on dialysis? This week our …
Read More »Practical Diabetes Care, 3rd Ed., Excerpt #20: Diabetes and the Eye Part 4 of 4
David Levy, MD, FRCP Cataract Diabetes is a strong risk factor for cataract, and it occurs earlier and progresses faster than in the non-diabetic population. Cortical cataract is the most frequent, with its typical radial spoke opacities. Indications for cataract surgery include impairment of vision that reduces quality of life, and …
Read More »Practical Diabetes Care, 3rd Ed., Excerpt #19: Diabetes and the Eye Part 3 of 4
David Levy, MD, FRCP Pre-proliferative retinopathy An important diagnosis, as there is a very high risk of progression to proliferative retinopathy and significant visual loss. Pre-proliferative changes are characterized by the following. Multiple (> 5) cotton-wool spots. Multiple large blot hemorrhages. Venous abnormalities: irregularities, beading, looping or reduplication. Intraretinal microvascular abnormalities: …
Read More »Practical Diabetes Care, 3rd Ed., Excerpt #18: Diabetes and the Eye Part 2 of 4
David Levy, MD, FRCP Non-proliferative diabetic retinopathy Background retinopathy Microaneurysms Small, red, intraretinal lesions usually found at the posterior pole of the eye, around the disc and macula. They occur in areas of capillary non-perfusion and show leakage of fluorescein. It is worthwhile estimating the number of microaneurysms as it has …
Read More »Practical Diabetes Care, 3rd Ed., Excerpt #17: Diabetes and the Eye Part 1 of 4
David Levy, MD, FRCP Introduction Diabetic retinopathy is the most common clinically significant microvascular complication of diabetes, but cataract is the most common ocular complication, with a prevalence of about 60% in those aged 30–54, five times more frequent than in those without diabetes. Diabetes is also associated with raised intraocular …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.